Dental products panel meeting
This article was originally published in The Gray Sheet
FDA's dental products advisory committee will hear "short presentations" on dental amalgams and dental product labeling at an Aug. 2-3 meeting in Rockville, Maryland. The issues "will be discussed at length at the next panel meeting," which is tentatively scheduled for Dec. 1-3, according to the agency. The bulk of the August meeting will be devoted to discussion of OTC antiplaque drug issues. For more information contact Jeanne Rippere at (301) 295-8186.
You may also be interested in...
The director of adult immunizations at Johns Hopkins International Vaccine Access Center talks to Scrip about undertaking a massive COVID-19 vaccination effort in the US.
P&G’s oral care business drove 35% of total category market growth in the firm’s fiscal 2020 and exemplifies its growth strategy for all segments – grow entire categories rather than take competitors’ market share, says CFO Jon Moeller.
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.